Overview

A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A comparison of the efficacy of Amisulpride and placebo in the prevention of PONV in patients at moderate-to-high risk of PONV.
Phase:
Phase 3
Details
Lead Sponsor:
Qilu Pharmaceutical (Hainan) Co., Ltd.
Treatments:
Amisulpride